Home/Filings/4/0001077183-25-000020
4//SEC Filing

Sherman Jeffrey Scott 4

Accession 0001077183-25-000020

CIK 0001077183other

Filed

Jan 15, 7:00 PM ET

Accepted

Jan 16, 4:13 PM ET

Size

16.9 KB

Accession

0001077183-25-000020

Insider Transaction Report

Form 4
Period: 2025-01-14
Sherman Jeffrey Scott
Chief Financial Officer
Transactions
  • Award

    Restricted Stock Unit

    2025-01-14+59,38259,382 total
    Exercise: $0.00From: 2026-04-13Common Stock (59,382 underlying)
Holdings
  • Restricted Stock Unit

    Exercise: $0.00Common Stock (46,606 underlying)
    46,606
  • Performance Stock Unit

    Exercise: $0.00From: 2027-02-23Common Stock (46,606 underlying)
    46,606
  • Stock Option (Right to Buy)

    Exercise: $19.65Exp: 2030-05-11Common Stock (73,016 underlying)
    73,016
  • Stock Option (Right to Buy)

    Exercise: $16.45Exp: 2034-02-23Common Stock (77,913 underlying)
    77,913
  • Performance Stock Unit

    Exercise: $0.00From: 2026-05-11Common Stock (39,016 underlying)
    39,016
  • Stock Option (Right to Buy)

    Exercise: $11.62Exp: 2029-12-05Common Stock (249,169 underlying)
    249,169
  • Common Stock

    123,754
  • Restricted Stock Unit

    Exercise: $0.00Common Stock (26,011 underlying)
    26,011
Footnotes (8)
  • [F1]Once vested, the shares of common stock are not subject to expiration.
  • [F2]On December 5, 2022, Mr. Sherman was granted 249,169 stock options. These awards vest ratably over four years with the first tranche vesting on December 7, 2023.
  • [F3]On May 11, 2023, Mr. Sherman was granted 73,016 stock options. These options vest ratably over the first three anniversary dates of the grant date.
  • [F4]On May 11, 2023, Mr. Sherman was granted 39,016 restricted stock units. These restricted stock units vest ratably over the first three anniversary dates of the grant date.
  • [F5]On May 11, 2023, Mr. Sherman was granted 39,016 performance stock units representing the number of shares that may vest at target performance. The maximum number of shares that may vest pursuant to the performance criteria is58,524. The number of performance stock units that may vest is based on the achievement of certain share growth goals based on the weighted average price of the Company's common stock over the 20-day trailing trading period at theapplicable measurement dates, subject to continued service with the Company.
  • [F6]On February 23, 2024, Mr. Sherman was granted 77,913 stock options. These options vest ratably over the first three anniversary dates of the grant date.
  • [F7]On February 23, 2024, Mr. Sherman was granted 46,606 restricted stock units. These restricted stock units vest ratably over the first three anniversary dates of the grant date.
  • [F8]On February 23, 2024, Mr. Sherman was granted 46,606 performance stock units representing the number of shares that may vest at target performance. The maximum number of shares that may vest pursuant to the performance criteriais 69,910. 50% of the number of performance stock units that may vest is based on the achievements of certain share growth goals based on the weighted average price of the Company's common stock over the 20-day trailing trading periodat the applicable measurement dates, subject to continued service with the Company. 50% of the number of performance stock units that may vest is based on the achievement of certain revenue growth goals based on the achievement of thecumulative fiscal year revenue goal at the applicable measurement amounts, subject to continued service with the Company

Issuer

NEOGENOMICS INC

CIK 0001077183

Entity typeother

Related Parties

1
  • filerCIK 0001463145

Filing Metadata

Form type
4
Filed
Jan 15, 7:00 PM ET
Accepted
Jan 16, 4:13 PM ET
Size
16.9 KB